• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Mirati - oncology?

Quote




























Meep once took the whole crew from Saint Louis to the Meramec Caverns for an offsite. He left all of us in the wine room to watch a sneak preview of Terminator 3. I never see Terminator 3!
 








































Not sure what you are talking about.
My RSU’s vested at around $160 mid 2021 and was considered regular income, which I paid income at the rate of 22%, subject to IRS and local tax withholding.

The RSU’s are worth next to nothing now. If I was to sell at the current market price, that would represent a significant capital gains loss which is tax deductible.

Basically, the government (IRS) taxed me in 2021 (and 2022) based on a “perceived “ income that is no longer real.

It’s similar to shorting the company. I’m hoping the stock will go as low as possible to increase my tax deduction.

Sad to be in this situation….,
 












Top Bottom
Back
Quote